首页 | 本学科首页   官方微博 | 高级检索  
检索        

西咪替丁对围手术期胃肠癌患者T细胞亚群的影响
引用本文:白德骄,杨国梁,袁宏银,李雁,王坤.西咪替丁对围手术期胃肠癌患者T细胞亚群的影响[J].世界华人消化杂志,2000,8(2):147-149.
作者姓名:白德骄  杨国梁  袁宏银  李雁  王坤
作者单位:湖北医科大学附属第二医院,肿瘤科,湖北省,武汉市,430071
摘    要:目的研究西咪替丁对围手术期胃肠癌患者外周血T细胞亚群免疫功能的影响.方法胃肠癌患者49例,以围手术期是否应用Cim(400mg,3次/d,po,术前7 d~10 d;600mg,2次/d,至术后10 d)随机分成治疗组和对照组.于入院时,手术前、手术后2,10 d各抽取外周血1次,用免疫细胞化学方法检测T细胞亚群(鼠抗人CD3,CD4,CD8单抗)的变化.结果与正常人相比,治疗组与对照组中的胃肠癌患者外周血CD3+,CD4+细胞数明显减少(P<0.01),CD8+细胞数明显增多(P<0.05),CD4+/CD8+比值明显降低(P<0.01).治疗组与对照组相比,入院时两者间各指标无显著性差别(P>0.05),术前1 d,术后2,10 d的CD3+,CD4+,CD4+/CD8+高于对照组(P<0.01).术后与术前相比,治疗组和对照组细胞免疫功能均下降,表现为CD3+,CD4+,CD4+/CD8+降低,CD8+升高(P<0.05),但治疗组免疫功能下降的幅度低于对照组.结论胃肠癌患者细胞免疫功能下降,手术使其细胞免疫功能进一步下调;Cim能增强患者细胞免疫功能,降低手术对机体免疫损害的程度.

关 键 词:胃肠肿瘤  T淋巴细胞亚群  西咪替丁  围手术期
修稿时间:1999年9月12日

Effects of cimetidine on T lymphocyte subsets in perioperative gastrointestinal cancer patients
De Jiao Bai,Guo Liang Yang,Hong Yin Yuan,Yan Li,Kun Wang.Effects of cimetidine on T lymphocyte subsets in perioperative gastrointestinal cancer patients[J].World Chinese Journal of Digestology,2000,8(2):147-149.
Authors:De Jiao Bai  Guo Liang Yang  Hong Yin Yuan  Yan Li  Kun Wang
Abstract:AIM To study the effects of cimetidine (Cim) on the immune function of peripheral blood lymphocyte subsets in patients with gastrointestinal cancer. METHODS Forty-nine patients were divided into treatment group ( n = 25 ) who took Cim during perioperative period, and control group (n = 24) who did not take any medicine. CD3 , CD4 and CD8 cells were measured by immunocytochemical stain method in the perioperative period.RESULTS Compared with normal control, the percentages of CD3 , CD4 cells and CD4 /CD8 ratio in patients with gastrointestinal cancer were significantly lower (P<0.01), and the percentage of CD8 cells was significantly higher (P<0.05). At admission, the parameters were not significantly different between treatment group and control group (P>0.05), while the percentages of CD3 , CD4 cells and CD4 / CD8 ratio before operation, on the 2nd and 10th postoperative days in the treatment group were significantly higher than those in the control group (P<0.01). The cellular immunity-positive cells in both groups were much lower after operation than before operation (P<0.05). However, the degree of decrease was much smaller in the treatment group than in the control group.CONCLUSION The cellular immunity-positive cells are lower in gastrointestinal cancer patients, and they are further down-regulated by operation. Cim can boost the patients' cellular immunity, and alleviate the damage to hosts' immunity due to operation.
Keywords:gastrointestinal neoplasms  T lymphocyte subsets  cimetidine  perioperative period
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《世界华人消化杂志》浏览原始摘要信息
点击此处可从《世界华人消化杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号